Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: A survey of European radiologists

European Journal of Radiology

Volumn 66, Issue 2, 2008, Pages 235-245

  Reddan, Donal ^a   Fishman, Elliot K ^b  

^a Merlin Park University Hospital   (Ireland)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Computed tomography; Contrast media; Contrast induced nephropathy; Radiologists; Risk factors; Survey

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DATA REDUCTION; HEALTH RISKS; PATIENT MONITORING; RISK ANALYSIS;

CONTRAST MEDIA (CM); CONTRAST-INDUCED NEPHROPATHY (CIN); MORBIDITY; RADIOLOGISTS; RENAL IMPAIRMENT;

RADIOLOGY;

CONTRAST MEDIUM;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DIABETES MELLITUS; EUROPE; FEMALE; HEALTH SURVEY; HEART FAILURE; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MALE; MORBIDITY; MORTALITY; NEPHROLOGIST; PRIORITY JOURNAL; RADIOLOGIST; RISK FACTOR;

CONFIDENCE INTERVALS; CONTRAST MEDIA; EUROPE; FEMALE; FIBROSIS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; QUESTIONNAIRES; RADIOGRAPHY; RISK FACTORS; SKIN DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43049136634     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.05.012     Document Type: Article

References (63)

1. Bartels E.D., Brun G.C., Gammeltoft A., and Gjorup P.A. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand 150 (1954) 297-302
2. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 53 (1998) 230-242
3. Berg K.J. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 34 (2000) 317-322
4. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002) 930-936
5. Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol 28 Suppl. 2 (2005) S3-S11
6. Manske C.L., Sprafka J.M., Strony J.T., and Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89 (1990) 615-620
7. Barrett B.J., Katzberg R.W., Thomsen H.S., et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 41 (2006) 815-821
8. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., and Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
9. Kalra M.K., Maher M.M., Rizzo S., and Saini S. Radiation exposure and projected risks with multidetector-row computed tomography scanning: clinical strategies and technologic developments for dose reduction. J Comput Assist Tomogr 28 Suppl. 1 (2004) S46-S49
10. ICC/ESOMAR International Code of Marketing and Social Research Practice. ESOMAR. Available at: http://www.esomar.org/web/show/id=43240. Accessed October 19, 2006.
11. MRS Standards and Guidelines. Market Research Society. Available at: http://www.mrs.org.uk/standards/guidelines.htm. Accessed October 19, 2006.
12. EphMRA Pharmaceutical Marketing Research Code of Conduct. European Pharmaceutical Marketing Research Association. Available at: http://www.ephmra.org/main.asp?page=487. Accessed October 19, 2006.
13. PBIRG. Pharmaceutical Business Intelligence and Research Group. Available at: http://www.pbirg.com/new/home/. Accessed October 19, 2006.
14. EAR Education Survey 2005. European Association of Radiology. Available at: http://www.ear-online.org. Accessed December 11, 2006.
15. Dodick D.W., Lipton R.B., Ferrari M.D., et al. Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project. Curr Pain Headache Rep 8 (2004) 435-442
16. Thomsen H.S. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 181 (2003) 1463-1471
17. Morcos S.K., and Thomsen H.S. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 28 (2003) 187-190
18. Gleeson T.G., and Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol 183 (2004) 1673-1689
19. Katzberg R.W. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 204 (1997) 297-312
20. Thomsen H.S., and Morcos S.K. Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Radiol 16 (2006) 1835-1840
21. Levey A.S., Berg R.L., Gassman J.J., Hall P.M., and Walker W.G. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl 27 (1989) S73-S80
22. Thomsen H.S., and Morcos S.K. In which patients should serum creatinine be measured before iodinated contrast medium administration?. Eur Radiol 15 (2005) 749-754
23. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
24. Liistro F., Falsini G., and Bolognese L. The clinical burden of contrast media-induced nephropathy. Ital Heart J 4 (2003) 668-676
25. Thomsen H.S., and Morcos S.K. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76 (2003) 513-518
26. Morcos S.K. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71 (1998) 357-365
27. Parfrey P.S., Griffiths S.M., Barrett B.J., et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both, A prospective controlled study. N Engl J Med 320 (1989) 143-149
28. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
29. Rudnick M.R., Goldfarb S., Wexler L., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47 (1995) 254-261
30. Rudnick M.R., Berns J.S., Cohen R.M., and Goldfarb S. Contrast media-associated nephrotoxicity. Semin Nephrol 17 (1997) 15-26
31. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
32. Weinrauch L.A., Healy R.W., Leland Jr. O.S., et al. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 86 (1977) 56-59
33. Katzberg R.W., and Barrett B.J. Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 243 (2007) 622-628
34. Nyman U., Almen T., Aspelin P., Hellstrom M., Kristiansson M., and Sterner G. Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol 46 (2005) 830-842
35. Becker C.R., and Reiser M.F. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 40 (2005) 672-675
36. Polena S., Yang S., Alam R., et al. Nephropathy in critically Ill patients without preexisting renal disease. Proc West Pharmacol Soc 48 (2005) 134-135
37. Mitchell A.M., and Kline J.A. Contrast nephropathy following computed tomography angiography of the chest for pulmonary embolism in the emergency department. J Thromb Haemost 5 (2007) 50-54
38. Waybill M.M., and Waybill P.N. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12 (2001) 3-9
39. Maitino A.J., Levin D.C., Parker L., Rao V.M., and Sunshine J.H. Nationwide trends in rates of utilization of noninvasive diagnostic imaging among the Medicare population between 1993 and 1999. Radiology 227 (2003) 113-117
40. Toms A.P., Cash C.J., Linton S.J., and Dixon A.K. Requests for body computed tomography: increasing workload, increasing indications and increasing age. Eur Radiol 11 (2001) 2633-2637
41. Rao Q.A., and Newhouse J.H. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 239 (2006) 392-397
42. Sabeti S., Schillinger M., Mlekusch W., Ahmadi R., and Minar E. Reduction in renal function after renal arteriography and after renal artery angioplasty. Eur J Vasc Endovasc Surg 24 (2002) 156-160
43. Dangas G., Iakovou I., Nikolsky E., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
44. Nikolsky E., and Mehran R. Understanding the consequences of contrast-induced nephropathy. Rev Cardiovasc Med 4 Suppl. 5 (2003) S10-S18
45. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
46. Gruberg L., Mehran R., Stone G.W., et al. Acute renal failure requiring hemodialysis after percutaneous coronary intervention: in-hospital and one-year outcomes. J Am Coll Cardiol 35 (2000) 53A
47. Gruberg L., Mehran R., Dangas G., et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 52 (2001) 409-416
48. Thomsen H.S., and Morcos S.K. ESUR guidelines on contrast media. Abdom Imaging 31 (2006) 131-140
49. Bartholomew B.A., Harjai K.J., Dukkipati S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
50. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
51. Rich M.W., and Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 150 (1990) 1237-1242
52. Stacul F., Adam A., Becker C., et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 98 6 Suppl. 1 (2006) 59-77
53. Hall K.A., Wong R.W., Hunter G.C., et al. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 53 (1992) 317-320
54. Nikolsky E., Aymong E.D., Dangas G., and Mehran R. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. Rev Cardiovasc Med 4 Suppl. 1 (2003) S7-S14
55. Jones C.A., McQuillan G.M., Kusek J.W., et al. Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 32 (1998) 992-999
56. Gussenhoven M.J., Ravensbergen J., van Bockel J.H., Feuth J.D., and Aarts J.C. Renal dysfunction after angiography; a risk factor analysis in patients with peripheral vascular disease. J Cardiovasc Surg (Torino) 32 (1991) 81-86
57. Kini A.S., Mitre C.A., Kamran M., et al. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. Am J Cardiol 89 (2002) 999-1002
58. Gruberg L., Mintz G.S., Mehran R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000) 1542-1548
59. Tadros G.M., Malik J.A., Manske C.L., et al. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. J Invasive Cardiol 17 (2005) 211-215
60. Konen E., Konen O., Katz M., Levy Y., Rozenman J., and Hertz M. Are referring clinicians aware of patients at risk from intravenous injection of iodinated contrast media?. Clin Radiol 57 (2002) 132-135
61. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-266
62. Snyder S., and Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Physician 72 (2005) 1723-1732
63. Stigant C., Stevens L., and Levin A. Nephrology: 4. Strategies for the care of adults with chronic kidney disease. Cmaj 168 (2003) 1553-1560